HAMAD GENERAL HOSPITAL
🇶🇦Qatar
- Country
- 🇶🇦Qatar
- Ownership
- -
- Established
- 1982-01-01
- Employees
- -
- Market Cap
- -
First-Ever RCT to Evaluate Human Albumin's Effectiveness in Aneurysmal Subarachnoid Hemorrhage Launches in Qatar
• Hamad General Hospital in Qatar initiates groundbreaking randomized controlled trial to assess human albumin's impact on clinical outcomes in aneurysmal subarachnoid hemorrhage patients.
• The three-year study will enroll 84 patients to compare albumin-enhanced fluid management versus standard crystalloid therapy, focusing on reducing cerebral vasospasm and improving neurological outcomes.
• The trial addresses a critical research gap, as aneurysmal subarachnoid hemorrhage affects working-age populations with up to 60% mortality rate in untreated cases.
© Copyright 2025. All Rights Reserved by MedPath